Applied DNA Sciences Inc
APDN5.620USD
0.000
Fechamento 11/04, 16:00（ET）Cotações atrasadas em 15 min
5.07MValor de mercado
PerdaP/L TTM
Mais detalhes de Applied DNA Sciences Inc Empresa
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Informações de Applied DNA Sciences Inc
Código da empresaAPDN
Nome da EmpresaApplied DNA Sciences Inc
Data de listagemAug 24, 2001
CEOMs. Judith Murrah
Número de funcionários46
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 24
Endereço50 Health Sciences Drive
CidadeSTONY BROOK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal11790
Telefone16312408800
Sitehttps://adnas.com/
Código da empresaAPDN
Data de listagemAug 24, 2001
CEOMs. Judith Murrah
Executivos da empresa Applied DNA Sciences Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Distribuição de ações
Atualizado em: seg, 3 de nov
Atualizado em: seg, 3 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
Outro
97.98%
Investidores
Investidores
Proporção
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
Outro
97.98%
Tipos de investidores
Investidores
Proporção
Hedge Fund
0.79%
Individual Investor
0.63%
Investment Advisor/Hedge Fund
0.41%
Investment Advisor
0.19%
Corporation
0.16%
Outro
97.82%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
59
89.41K
1.51%
+65.56K
2025Q2
62
34.98K
6.73%
-8.84K
2025Q1
84
45.20K
34.86%
+11.50K
2024Q4
79
25.60M
46.39%
+1.44M
2024Q3
74
1.08M
9.78%
+703.30K
2024Q2
73
1.19M
10.83%
+424.27K
2024Q1
67
243.32K
209.10%
+86.27K
2023Q4
64
96.98K
13.46%
-84.74K
2023Q3
66
149.12K
21.28%
-82.31K
2023Q2
68
142.47K
21.43%
-74.27K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Anson Funds Management LP.
46.51K
3.6%
+41.94K
+918.33%
Jun 30, 2025
Sabby Management, LLC
24.36K
1.89%
+17.39K
+249.63%
Jun 30, 2025
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Financial Services, Inc.
11.13K
0.86%
+8.82K
+381.65%
Jun 30, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
Tower Research Capital LLC
222.00
0.02%
+190.00
+593.75%
Jun 30, 2025
SBI Securities Co., Ltd.
146.00
0.01%
+79.00
+117.91%
Jun 30, 2025
Grossman (Bruce)
111.00
0.01%
+111.00
--
Feb 02, 2024
Sanctuary Advisors, LLC
20.00
0%
+20.00
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Data
Tipo
Proporção
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
